Lawrence Long, MCom, PhD
Research Assistant Professor
Boston University School of Public Health
Dept of Global Health

PhD, University of the Witwatersrand
M.Com., University of the Witwatersrand
B.Bus.Sci., University of Cape Town



Lawrence Long (MCom, PhD) is a health economist and public health policy researcher. He is a Research Assistant Professor at the Boston University School of Public Health and holds a joint appointment at the University of Witwatersrand (Johannesburg, South Africa). He has more than 12 years of experience conducting applied research on the economic impact of HIV, tuberculosis and associated conditions within South Africa and sub-Saharan Africa. Prior to his appointment at Boston University he led a growing South African research group as the deputy director and has extensive experience in organizational management, leadership and grant management. Lawrence did his undergraduate degree in business science with a specialization in economics and finance and then went on to focus on economics and its application to public health in his graduate studies. Currently he is the Program Director of a multi-year USAID Innovations Award and the local principal investigator of a NIH funded clinical trial of same day HIV treatment initiation.
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Onoya D, Hirasen K, van den Berg L, Miot J, Long LC, Fox MP. Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa. Drug Saf. 2018 Dec; 41(12):1343-1353.View Related Profiles. PMID: 30043384.
     
  2. Brennan AT, Jamieson L, Crowther NJ, Fox MP, George JA, Berry KM, Stokes A, Maskew M, Sanne I, Long L, Cassim N, Rosen S. Prevalence, incidence, predictors, treatment, and control of hypertension among HIV-positive adults on antiretroviral treatment in public sector treatment programs in South Africa. PLoS One. 2018; 13(10):e0204020.View Related Profiles. PMID: 30281618.
     
  3. Hendrickson CJ, Pascoe SJS, Huber AN, Moolla A, Maskew M, Long LC, Fox MP. "My future is bright…I won't die with the cause of AIDS": ten-year patient ART outcomes and experiences in South Africa. J Int AIDS Soc. 2018 Oct; 21(10):e25184.View Related Profiles. PMID: 30318848.
     
  4. Shearer K, Evans D, Xhosa B, Hirasen K, Bracken C, Mahomed K, Long L, Fox MP. Low prevalence of depressive symptoms among stable patients on antiretroviral therapy in Johannesburg, South Africa. PLoS One. 2018; 13(9):e0203797.View Related Profiles. PMID: 30252844; DOI: 10.1371/journal.pone.0203797;.
     
  5. Maskew M, Jamieson L, Mohomi G, Long L, Mongwenyana C, Nyoni C, Mokaba D, Fox MP, Sanne I, Rosen S. Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care. PLoS One. 2018; 13(8):e0201955.View Related Profiles. PMID: 30161147.
     
  6. Bonawitz R, Brennan AT, Long L, Heeren T, Maskew M, Sanne I, Fox MP. Regimen durability in HIV-infected children and adolescents initiating first-line antiretroviral therapy in a large public sector HIV cohort in South Africa. Trop Med Int Health. 2018 Jun; 23(6):650-660.View Related Profiles. PMID: 29656449.
     
  7. Evans D, Musakwa N, Nattey C, Bor J, Lönnermark E, Nyasulu P, Long L. Knowledge, risk perception and barriers to accessing care for HIV and Tuberculosis among adolescents and young adults aged 18 – 25 years in Johannesburg, South Africa. The South African Journal of Child Health. 2018; 2018(Special):S19-S31. View Publication
  8. Budgell EP, Evans D, Leuner R, Long L, Rosen S. The costs and outcomes of paediatric tuberculosis treatment at primary healthcare clinics in Johannesburg, South Africa. S Afr Med J. 2018 Apr 25; 108(5):423-431. PMID: 29843858.
     
  9. Meyer-Rath G, Johnson LF, Pillay Y, Blecher M, Brennan AT, Long L, Moultrie H, Sanne I, Fox MP, Rosen S. Changing the South African national antiretroviral therapy guidelines: The role of cost modelling. PLoS One. 2017; 12(10):e0186557.View Related Profiles. PMID: 29084275.
     
  10. Clouse K, Mongwenyana C, Musina M, Bokaba D, Long L, Maskew M, Ahonkhai A, Fox MP. Acceptability and feasibility of a financial incentive intervention to improve retention in HIV care among pregnant women in Johannesburg, South Africa. AIDS Care. 2018 Apr; 30(4):453-460.View Related Profiles. PMID: 29067861.
     
Showing 10 of 62 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 62 publications over 10 distinct years, with a maximum of 16 publications in 2016

YearPublications
20083
20105
20113
20125
20136
20143
20152
201616
201711
20188
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Health Economics
Economic Evaluation
Cost Analysis
Cost Effectiveness Analysis
HIV
South Africa
Contact for Mentoring:


801 Massachusetts Avenue, Crosstown Center CT369
Boston MA 02118
Google Map


Long's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department